Dysbiosis News and Research

RSS

Dysbiosis is a condition caused by an imbalance in the bacterial community (microbiome) of the human gut. Dysbiosis disrupts the ecoystsem of the gut, resulting in symptoms such as diarrhea, constipation, bloating, and indigestion, among others.

Probiotics do not improve unhealthy vaginal flora, study shows

Pregnancy chances in IVF can be affected by many factors including the type of bacteria which naturally colonize the reproductive tract.

4 Jul 2022

Clinical risk and protective factors for the presence and persistence of abdominal pain-related disorders of gut-brain interaction

The current study carries forward what is known about the risk of AP-DGBI conferred by various factors such as sex, infectious gastroenteritis, trauma, abuse, stress, psychological factors, somatic symptoms, family history, smoking, and drug abuse.

17 Jun 2022

How does gut microbiota impact mental health in 18–25s?

In a recently published article in the International Journal of Molecular Sciences, scientists have described the importance of the gut-brain-microbiota axis in establishing optimal mental health in emerging adulthood (ages 18–25).

16 Jun 2022

Fecal microbiota transplant shows durable effect in treating irritable bowel syndrome

A new study discusses the efficacy of fecal transplant in patients with IBS three years after the procedure was performed.

16 Jun 2022

Association of neuronal and non-neuronal GABA with neuropsychiatric illness in COVID-19 patients

A new study published in the journal Reports focused on the hijacking of the pancreatic, endothelial, and gut GABA by SARS-CoV-2 and its associated pathology along with interventions.

10 Jun 2022

Gastrointestinal complications caused by SARS-CoV-2

scientists discuss the gastrointestinal complications associated with COVID-19.

7 Jun 2022

The enigma of post-acute infection syndromes

In a recent review published in the journal Nature Medicine, researchers summarized known literature findings of the unexplained post-acute infection syndromes (PAISs).

20 May 2022

Studying immunomodulatory effects of microbiota helps design prophylactic and therapeutic interventions against COVID-19

Researchers reviewed the potential clinically relevant mechanisms by which microbiota and microbiota-derived metabolites influence the host immune responses to SARS-CoV-2 infection.

3 May 2022

Antibiotics may disrupt microbiome to cause recurrent UTIs

A study by researchers at Washington University School of Medicine in St. Louis and the Broad Institute of MIT and Harvard suggests that women who get recurrent urinary tract infections (UTIs) may be caught in a vicious cycle in which antibiotics given to eradicate one infection predispose them to develop another.

2 May 2022

Epigenetic abnormalities in hematopoietic cells during fetal development cause idiopathic autism

An international research group led by Professor Toru Takumi (Senior Visiting Scientist, RIKEN Center for Biosystems Dynamics Research) and Researcher Chia-wen Lin at Kobe University Graduate School of Medicine has shown that idiopathic autism is caused by epigenetic abnormalities in hematopoietic cells during fetal development, which results in immune dysregulation in the brain and gut.

2 May 2022

Dietary influences on long COVID in children

A new study discusses possible mechanisms of long COVID in children and how they might relate to their dietary intake of important vitamins and elements.

13 Apr 2022

Exploring the vital connection between gut microbes, physical activity, and health

Our bowels accommodate billions of active microbes that affect the health, a fact that is arousing increasing interest also among athletes.

26 Mar 2022

Altered microbiomes in SARS-CoV-2 infection pose threat of antibiotic resistance

A new study discusses changes in the microbiota of various parts of the body with SARS-CoV-2 infection.

27 Feb 2022

Study suggests tea polyphenols may modulate COVID-19 via intestinal microbiota

A new study discusses the state of current knowledge about the potential use of tea polyphenols in the prevention and treatment of COVID-19.

16 Feb 2022

Estonian Microbiome Project demonstrates the impact of long-term antibiotic use on the microbiome

Estonian Microbiome Project, using electronic health data from more than 2500 biobank participants finds long-term antibiotic usage, independent from recent administration, has an impact on the microbiome, partly explaining the common bacterial signatures overlapping between diseases.

16 Feb 2022

Dysbiosis News and Research

Further Reading

Probiotics do not improve unhealthy vaginal flora, study shows

Clinical risk and protective factors for the presence and persistence of abdominal pain-related disorders of gut-brain interaction

How does gut microbiota impact mental health in 18–25s?

Fecal microbiota transplant shows durable effect in treating irritable bowel syndrome

Association of neuronal and non-neuronal GABA with neuropsychiatric illness in COVID-19 patients

Gastrointestinal complications caused by SARS-CoV-2

The enigma of post-acute infection syndromes

Studying immunomodulatory effects of microbiota helps design prophylactic and therapeutic interventions against COVID-19

Antibiotics may disrupt microbiome to cause recurrent UTIs

Epigenetic abnormalities in hematopoietic cells during fetal development cause idiopathic autism

Dietary influences on long COVID in children

Exploring the vital connection between gut microbes, physical activity, and health

Altered microbiomes in SARS-CoV-2 infection pose threat of antibiotic resistance

Study suggests tea polyphenols may modulate COVID-19 via intestinal microbiota

Estonian Microbiome Project demonstrates the impact of long-term antibiotic use on the microbiome

Exploring human milk oligosaccharides as a method of COVID-19 prevention

Microbial characteristics of COVID-19

Role of leptin in immune modulation and pathophysiology of COVID-19

Severe COVID-19 found to be associated with disrupted intestinal Peyer’s patches

Environmental microbiome's impact on COVID-19 mortality

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News